| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 48 | 2018 | 4433 | 3.260 |
Why?
|
| Kruppel-Like Transcription Factors | 21 | 2018 | 504 | 2.970 |
Why?
|
| Endothelial Cells | 20 | 2016 | 3548 | 1.770 |
Why?
|
| Hemodynamics | 9 | 2016 | 4160 | 1.110 |
Why?
|
| Stress, Mechanical | 16 | 2018 | 1674 | 0.920 |
Why?
|
| Simvastatin | 6 | 2018 | 346 | 0.840 |
Why?
|
| Hepatic Stellate Cells | 2 | 2014 | 119 | 0.830 |
Why?
|
| Mechanotransduction, Cellular | 6 | 2018 | 528 | 0.810 |
Why?
|
| Biomimetic Materials | 2 | 2016 | 172 | 0.780 |
Why?
|
| Atherosclerosis | 10 | 2018 | 3400 | 0.720 |
Why?
|
| Nitric Oxide Synthase | 15 | 2005 | 908 | 0.720 |
Why?
|
| Shear Strength | 6 | 2013 | 160 | 0.710 |
Why?
|
| Hydrodynamics | 2 | 2011 | 168 | 0.700 |
Why?
|
| Organ Preservation | 5 | 2012 | 382 | 0.690 |
Why?
|
| Arteriosclerosis | 4 | 2005 | 1056 | 0.620 |
Why?
|
| Liver Cirrhosis, Experimental | 3 | 2012 | 29 | 0.600 |
Why?
|
| Perfusion | 4 | 2010 | 1373 | 0.540 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 379 | 0.490 |
Why?
|
| Biomimetics | 1 | 2016 | 171 | 0.490 |
Why?
|
| Cells, Cultured | 34 | 2016 | 18937 | 0.470 |
Why?
|
| Jugular Veins | 2 | 2006 | 210 | 0.450 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1525 | 0.450 |
Why?
|
| Gene Expression | 5 | 2018 | 7568 | 0.450 |
Why?
|
| Umbilical Veins | 10 | 2011 | 426 | 0.430 |
Why?
|
| Stilbenes | 2 | 2009 | 155 | 0.390 |
Why?
|
| Gene Expression Regulation | 17 | 2016 | 11874 | 0.390 |
Why?
|
| Glycocalyx | 1 | 2012 | 97 | 0.380 |
Why?
|
| Embryonic Development | 1 | 2016 | 721 | 0.380 |
Why?
|
| Caveolins | 4 | 2003 | 102 | 0.380 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2013 | 1850 | 0.370 |
Why?
|
| Microfluidics | 1 | 2016 | 651 | 0.370 |
Why?
|
| Nitric Oxide | 14 | 2016 | 2135 | 0.360 |
Why?
|
| Hemorheology | 5 | 2016 | 144 | 0.360 |
Why?
|
| Equipment Design | 2 | 2016 | 3501 | 0.350 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2012 | 3244 | 0.350 |
Why?
|
| Cell Differentiation | 8 | 2014 | 11514 | 0.340 |
Why?
|
| Blood Vessels | 4 | 2010 | 1113 | 0.330 |
Why?
|
| Ribonucleosides | 1 | 2009 | 79 | 0.320 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 85 | 0.310 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 794 | 0.310 |
Why?
|
| Cell Lineage | 2 | 2016 | 2554 | 0.300 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 246 | 0.300 |
Why?
|
| Cryopreservation | 2 | 2010 | 728 | 0.300 |
Why?
|
| Pulsatile Flow | 4 | 2011 | 321 | 0.290 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2015 | 1492 | 0.280 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2015 | 699 | 0.280 |
Why?
|
| Models, Cardiovascular | 2 | 2010 | 981 | 0.270 |
Why?
|
| Hypertension, Portal | 4 | 2012 | 226 | 0.270 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 597 | 0.260 |
Why?
|
| Rats, Wistar | 4 | 2014 | 1848 | 0.260 |
Why?
|
| Microvessels | 1 | 2010 | 577 | 0.250 |
Why?
|
| Liver Circulation | 2 | 2012 | 159 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2004 | 3777 | 0.250 |
Why?
|
| Blood Circulation | 1 | 2006 | 248 | 0.240 |
Why?
|
| Hematopoiesis | 2 | 2011 | 2049 | 0.240 |
Why?
|
| HSP90 Heat-Shock Proteins | 4 | 2004 | 424 | 0.240 |
Why?
|
| Oxygen | 1 | 2016 | 4226 | 0.240 |
Why?
|
| Phenotype | 12 | 2016 | 16571 | 0.240 |
Why?
|
| Drug Discovery | 1 | 2012 | 1051 | 0.230 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1926 | 0.230 |
Why?
|
| Models, Biological | 4 | 2016 | 9461 | 0.230 |
Why?
|
| Animals | 49 | 2017 | 168201 | 0.230 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5863 | 0.220 |
Why?
|
| Embryonic Stem Cells | 3 | 2014 | 1262 | 0.220 |
Why?
|
| beta-Cyclodextrins | 1 | 2003 | 70 | 0.220 |
Why?
|
| Nitric Oxide Synthase Type III | 9 | 2013 | 705 | 0.220 |
Why?
|
| E-Selectin | 3 | 2008 | 577 | 0.220 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 3419 | 0.210 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 287 | 0.210 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1569 | 0.210 |
Why?
|
| Palmitic Acids | 3 | 1996 | 53 | 0.200 |
Why?
|
| Membrane Microdomains | 1 | 2003 | 206 | 0.200 |
Why?
|
| Organ Preservation Solutions | 3 | 2012 | 100 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 829 | 0.200 |
Why?
|
| Renal Circulation | 2 | 2013 | 291 | 0.200 |
Why?
|
| Up-Regulation | 4 | 2014 | 4117 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2011 | 3394 | 0.190 |
Why?
|
| Trans-Activators | 4 | 2005 | 2852 | 0.190 |
Why?
|
| Arteries | 3 | 2002 | 1122 | 0.190 |
Why?
|
| Carotid Arteries | 2 | 2007 | 941 | 0.190 |
Why?
|
| Cell Culture Techniques | 4 | 2013 | 1662 | 0.180 |
Why?
|
| Stress, Physiological | 3 | 2015 | 1403 | 0.180 |
Why?
|
| Reperfusion Injury | 3 | 2013 | 1023 | 0.180 |
Why?
|
| Mechanoreceptors | 1 | 2001 | 186 | 0.170 |
Why?
|
| MADS Domain Proteins | 2 | 2009 | 19 | 0.170 |
Why?
|
| MAP Kinase Kinase 5 | 2 | 2009 | 10 | 0.170 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2009 | 102 | 0.170 |
Why?
|
| Protective Agents | 2 | 2014 | 150 | 0.170 |
Why?
|
| Cell Movement | 6 | 2008 | 5200 | 0.170 |
Why?
|
| Fibroblasts | 2 | 2014 | 4137 | 0.170 |
Why?
|
| Blood Flow Velocity | 4 | 2015 | 1370 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 933 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2009 | 66 | 0.170 |
Why?
|
| Rats | 13 | 2014 | 23717 | 0.160 |
Why?
|
| Transfection | 7 | 2014 | 5766 | 0.150 |
Why?
|
| Stem Cells | 1 | 2011 | 3516 | 0.150 |
Why?
|
| DNA, Complementary | 4 | 2009 | 1989 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 5 | 2018 | 5780 | 0.150 |
Why?
|
| Signal Transduction | 12 | 2018 | 23416 | 0.150 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2358 | 0.140 |
Why?
|
| Splanchnic Circulation | 2 | 1999 | 119 | 0.140 |
Why?
|
| Dinoprostone | 2 | 2015 | 597 | 0.140 |
Why?
|
| Graft Rejection | 1 | 2010 | 4446 | 0.140 |
Why?
|
| Cells, Immobilized | 1 | 2016 | 35 | 0.140 |
Why?
|
| Aorta | 5 | 2016 | 2041 | 0.140 |
Why?
|
| Humans | 59 | 2018 | 760617 | 0.140 |
Why?
|
| RNA | 1 | 2006 | 2713 | 0.130 |
Why?
|
| Kidney | 1 | 2012 | 7045 | 0.130 |
Why?
|
| RNA, Messenger | 9 | 2016 | 12758 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 2 | 2015 | 796 | 0.130 |
Why?
|
| Cattle | 9 | 2005 | 3841 | 0.130 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 1496 | 0.130 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2016 | 142 | 0.130 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 456 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2007 | 2864 | 0.130 |
Why?
|
| Rheology | 1 | 2016 | 347 | 0.120 |
Why?
|
| Gene Expression Profiling | 4 | 2009 | 9417 | 0.120 |
Why?
|
| Caveolin 1 | 4 | 2003 | 255 | 0.120 |
Why?
|
| Phosphorylation | 7 | 2013 | 8311 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2002 | 7847 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2015 | 485 | 0.110 |
Why?
|
| von Willebrand Factor | 2 | 2016 | 676 | 0.110 |
Why?
|
| Liver | 4 | 2012 | 7512 | 0.110 |
Why?
|
| Capillaries | 2 | 2016 | 756 | 0.110 |
Why?
|
| Surface Properties | 1 | 2016 | 1161 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2013 | 344 | 0.110 |
Why?
|
| Cell Line | 6 | 2013 | 15576 | 0.110 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2013 | 68 | 0.110 |
Why?
|
| Cell Adhesion | 4 | 2010 | 3088 | 0.110 |
Why?
|
| Materials Testing | 1 | 2016 | 862 | 0.100 |
Why?
|
| Models, Animal | 3 | 2012 | 2109 | 0.100 |
Why?
|
| Microcirculation | 5 | 2007 | 1272 | 0.100 |
Why?
|
| American Heart Association | 1 | 2017 | 1039 | 0.100 |
Why?
|
| Endothelial Growth Factors | 4 | 1998 | 673 | 0.100 |
Why?
|
| Mosaicism | 1 | 2016 | 474 | 0.100 |
Why?
|
| Lovastatin | 1 | 2012 | 115 | 0.100 |
Why?
|
| Lymphokines | 4 | 1998 | 925 | 0.100 |
Why?
|
| Quail | 1 | 2011 | 40 | 0.100 |
Why?
|
| Syndecan-1 | 1 | 2012 | 163 | 0.100 |
Why?
|
| Mice | 18 | 2016 | 81368 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4512 | 0.100 |
Why?
|
| Heparitin Sulfate | 1 | 2012 | 223 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 2 | 2001 | 2644 | 0.100 |
Why?
|
| Antifibrinolytic Agents | 1 | 2014 | 287 | 0.090 |
Why?
|
| Interferon-beta | 1 | 2013 | 345 | 0.090 |
Why?
|
| Vanadates | 2 | 2004 | 82 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 382 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2004 | 1301 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2015 | 1463 | 0.090 |
Why?
|
| DNA Primers | 3 | 2005 | 2817 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2012 | 277 | 0.090 |
Why?
|
| Carbon Tetrachloride | 1 | 2010 | 72 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 22115 | 0.090 |
Why?
|
| Organ Transplantation | 2 | 2013 | 1157 | 0.090 |
Why?
|
| Portal Pressure | 1 | 2010 | 60 | 0.090 |
Why?
|
| Cryoprotective Agents | 1 | 2012 | 128 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2016 | 4391 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2639 | 0.090 |
Why?
|
| Enzyme Activation | 5 | 2007 | 3591 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2009 | 1759 | 0.090 |
Why?
|
| Heptanoic Acids | 1 | 2012 | 344 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4570 | 0.090 |
Why?
|
| Chimera | 1 | 2011 | 453 | 0.090 |
Why?
|
| Random Allocation | 1 | 2014 | 2392 | 0.090 |
Why?
|
| Coculture Techniques | 2 | 2012 | 1336 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 1998 | 748 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1333 | 0.080 |
Why?
|
| Chick Embryo | 1 | 2011 | 982 | 0.080 |
Why?
|
| Systems Biology | 1 | 2013 | 481 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 592 | 0.080 |
Why?
|
| Biological Assay | 1 | 2012 | 626 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 5 | 2004 | 1349 | 0.080 |
Why?
|
| Adenylate Kinase | 1 | 2009 | 102 | 0.080 |
Why?
|
| Liver Diseases | 1 | 1998 | 1297 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 1670 | 0.080 |
Why?
|
| Internet | 1 | 2001 | 3090 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 2802 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15498 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 306 | 0.080 |
Why?
|
| Delayed Graft Function | 1 | 2009 | 54 | 0.080 |
Why?
|
| Cold Temperature | 2 | 2010 | 784 | 0.080 |
Why?
|
| Tumor Necrosis Factors | 1 | 2008 | 107 | 0.070 |
Why?
|
| Transcription, Genetic | 5 | 2010 | 7583 | 0.070 |
Why?
|
| Interleukin-1 | 4 | 2005 | 1248 | 0.070 |
Why?
|
| Umbilical Arteries | 1 | 2008 | 79 | 0.070 |
Why?
|
| Leukocyte Rolling | 1 | 2007 | 69 | 0.070 |
Why?
|
| Aortic Valve | 2 | 2010 | 1955 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 843 | 0.070 |
Why?
|
| Thrombosis | 2 | 2016 | 2943 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 808 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1884 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 2456 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 11069 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2009 | 532 | 0.070 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2006 | 55 | 0.070 |
Why?
|
| Tenascin | 1 | 2006 | 61 | 0.070 |
Why?
|
| Aorta, Abdominal | 1 | 2009 | 625 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2012 | 877 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2009 | 1646 | 0.070 |
Why?
|
| Pyrroles | 1 | 2012 | 1125 | 0.070 |
Why?
|
| Tyrosine | 2 | 2003 | 1440 | 0.070 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 1285 | 0.060 |
Why?
|
| Tretinoin | 1 | 2009 | 519 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2001 | 7960 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 315 | 0.060 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 4236 | 0.060 |
Why?
|
| Cell Communication | 1 | 2012 | 1654 | 0.060 |
Why?
|
| Base Sequence | 4 | 2005 | 12421 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 4341 | 0.060 |
Why?
|
| Elastin | 1 | 2006 | 298 | 0.060 |
Why?
|
| Kinetics | 3 | 2005 | 6370 | 0.060 |
Why?
|
| Osteopontin | 1 | 2006 | 301 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 373 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2016 | 14389 | 0.060 |
Why?
|
| Cadaver | 1 | 2009 | 1358 | 0.060 |
Why?
|
| Pulmonary Circulation | 2 | 1997 | 737 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18221 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2475 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1096 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1503 | 0.060 |
Why?
|
| Monocytes | 1 | 2013 | 2565 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2003 | 299 | 0.060 |
Why?
|
| Caveolae | 1 | 2003 | 54 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2009 | 988 | 0.050 |
Why?
|
| Cyclodextrins | 1 | 2003 | 66 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 131 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2812 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 292 | 0.050 |
Why?
|
| Ischemia | 1 | 2012 | 1884 | 0.050 |
Why?
|
| Lymphangiogenesis | 1 | 2004 | 171 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2017 | 3426 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2003 | 364 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 613 | 0.050 |
Why?
|
| Ultrasonics | 1 | 2004 | 207 | 0.050 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2002 | 56 | 0.050 |
Why?
|
| Chemokines | 2 | 2007 | 954 | 0.050 |
Why?
|
| Quinones | 2 | 1999 | 78 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6174 | 0.050 |
Why?
|
| Apoptosis | 2 | 2010 | 9476 | 0.050 |
Why?
|
| Male | 15 | 2014 | 360358 | 0.050 |
Why?
|
| Benzoquinones | 2 | 1999 | 198 | 0.050 |
Why?
|
| Methoxamine | 2 | 1999 | 45 | 0.050 |
Why?
|
| Venules | 1 | 2001 | 161 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6224 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2012 | 1532 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2009 | 2764 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3794 | 0.040 |
Why?
|
| Inflammation | 4 | 2013 | 10760 | 0.040 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 411 | 0.040 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2011 | 1642 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 537 | 0.040 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 962 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 685 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 1998 | 3492 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2004 | 773 | 0.040 |
Why?
|
| Binding Sites | 3 | 2014 | 6051 | 0.040 |
Why?
|
| Arterioles | 1 | 2001 | 250 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7389 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 2 | 1999 | 318 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2013 | 254 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 852 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14648 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2001 | 17629 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1336 | 0.040 |
Why?
|
| Palmitic Acid | 2 | 1996 | 149 | 0.040 |
Why?
|
| Macrophages | 3 | 2015 | 5758 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1998 | 1085 | 0.040 |
Why?
|
| Receptors, Vitronectin | 1 | 1998 | 46 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 1998 | 138 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2003 | 1027 | 0.040 |
Why?
|
| Thrombomodulin | 2 | 2011 | 105 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2003 | 1056 | 0.040 |
Why?
|
| Genotype | 1 | 2012 | 12978 | 0.040 |
Why?
|
| Protein Transport | 1 | 2003 | 1966 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 1788 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1998 | 178 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2001 | 561 | 0.040 |
Why?
|
| Collagen | 3 | 2001 | 2634 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 813 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2008 | 3095 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2004 | 1718 | 0.040 |
Why?
|
| Golgi Apparatus | 2 | 1996 | 404 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1431 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 2 | 1999 | 654 | 0.030 |
Why?
|
| Veins | 1 | 2001 | 767 | 0.030 |
Why?
|
| Ligands | 1 | 2003 | 3268 | 0.030 |
Why?
|
| Histamine | 1 | 1998 | 499 | 0.030 |
Why?
|
| Protein Binding | 3 | 1997 | 9345 | 0.030 |
Why?
|
| COS Cells | 1 | 1998 | 1130 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 384 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1300 | 0.030 |
Why?
|
| Mesonephros | 1 | 2015 | 42 | 0.030 |
Why?
|
| Leukocytes | 1 | 2003 | 2023 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3805 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 29600 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 149 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1997 | 930 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2014 | 69 | 0.030 |
Why?
|
| Reference Values | 2 | 2001 | 4919 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23972 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1998 | 678 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 669 | 0.030 |
Why?
|
| Calcium | 3 | 2013 | 5717 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3792 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 695 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1996 | 592 | 0.030 |
Why?
|
| Sp1 Transcription Factor | 1 | 2014 | 140 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 210 | 0.030 |
Why?
|
| Liver Transplantation | 2 | 2012 | 2329 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 691 | 0.030 |
Why?
|
| Ephrin-B2 | 2 | 2004 | 40 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1996 | 730 | 0.030 |
Why?
|
| Phosphates | 1 | 1996 | 769 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2013 | 110 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1997 | 3680 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1743 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10175 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 502 | 0.030 |
Why?
|
| Vasodilation | 2 | 2011 | 962 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2008 | 1128 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2013 | 169 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2004 | 3045 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 145 | 0.030 |
Why?
|
| Neutrophils | 2 | 2013 | 3763 | 0.030 |
Why?
|
| Raffinose | 1 | 2012 | 53 | 0.020 |
Why?
|
| Cell Division | 4 | 2004 | 4457 | 0.020 |
Why?
|
| Enzyme Inhibitors | 3 | 2014 | 3705 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2013 | 238 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1999 | 8166 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 340 | 0.020 |
Why?
|
| Blotting, Western | 4 | 2002 | 5034 | 0.020 |
Why?
|
| Cytokines | 1 | 2006 | 7373 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2467 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1002 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2425 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1997 | 6520 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3608 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17878 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12116 | 0.020 |
Why?
|
| Allopurinol | 1 | 2012 | 198 | 0.020 |
Why?
|
| Estradiol | 1 | 1997 | 1937 | 0.020 |
Why?
|
| Prenylation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1997 | 802 | 0.020 |
Why?
|
| Acyl Coenzyme A | 1 | 2010 | 56 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12661 | 0.020 |
Why?
|
| Procaine | 1 | 2010 | 60 | 0.020 |
Why?
|
| Corneal Neovascularization | 2 | 2004 | 185 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 9172 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2509 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9529 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 634 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2009 | 21 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 229 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2016 | 6233 | 0.020 |
Why?
|
| Mannitol | 1 | 2010 | 177 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 1963 | 0.020 |
Why?
|
| Glutathione | 1 | 2012 | 582 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 13441 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 2 | 2007 | 1602 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 516 | 0.020 |
Why?
|
| Neoplasms | 1 | 1998 | 22131 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 74115 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1389 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5110 | 0.020 |
Why?
|
| Homeostasis | 2 | 2011 | 3321 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3688 | 0.020 |
Why?
|
| omega-N-Methylarginine | 2 | 1997 | 108 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 3842 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2008 | 2481 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1995 | 1971 | 0.020 |
Why?
|
| Software | 1 | 2001 | 4431 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1927 | 0.020 |
Why?
|
| Adenosine | 1 | 2012 | 805 | 0.020 |
Why?
|
| Gels | 2 | 1999 | 420 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 358 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 319 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 20074 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 721 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1998 | 4935 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 4209 | 0.020 |
Why?
|
| Isoenzymes | 2 | 2002 | 1687 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2007 | 512 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4269 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2004 | 63 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 3730 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 652 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2004 | 127 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 277 | 0.010 |
Why?
|
| Biological Transport | 2 | 2000 | 2089 | 0.010 |
Why?
|
| Proteins | 1 | 1998 | 6030 | 0.010 |
Why?
|
| Vasculitis | 1 | 2007 | 522 | 0.010 |
Why?
|
| Thromboplastin | 1 | 2005 | 286 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1692 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2002 | 44 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 592 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 578 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 318 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 6074 | 0.010 |
Why?
|
| Collagen Type XVIII | 1 | 2001 | 52 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10754 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 2231 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2424 | 0.010 |
Why?
|
| Endostatins | 1 | 2001 | 168 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2001 | 162 | 0.010 |
Why?
|
| Cytotoxins | 1 | 2001 | 153 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 187 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 602 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 596 | 0.010 |
Why?
|
| Calmodulin | 1 | 2000 | 218 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 2112 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2001 | 276 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2002 | 696 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 890 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5463 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 1154 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1998 | 131 | 0.010 |
Why?
|
| Angiopoietin-1 | 1 | 1999 | 122 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 927 | 0.010 |
Why?
|
| Vitronectin | 1 | 1998 | 40 | 0.010 |
Why?
|
| Integrin alphaV | 1 | 1998 | 54 | 0.010 |
Why?
|
| Female | 5 | 2010 | 392148 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1997 | 29 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 4345 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1697 | 0.010 |
Why?
|
| Canavanine | 1 | 1997 | 14 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1997 | 37 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1997 | 150 | 0.010 |
Why?
|
| Nitroarginine | 1 | 1997 | 66 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1999 | 629 | 0.010 |
Why?
|
| Insulin | 1 | 2012 | 6593 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1998 | 183 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2001 | 741 | 0.010 |
Why?
|
| Ornithine | 1 | 1997 | 79 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 1998 | 350 | 0.010 |
Why?
|
| Thiourea | 1 | 1997 | 68 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1997 | 531 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1998 | 255 | 0.010 |
Why?
|
| Citrulline | 1 | 1997 | 106 | 0.010 |
Why?
|
| Growth Substances | 1 | 1999 | 768 | 0.010 |
Why?
|
| Cornea | 1 | 2004 | 1332 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 260 | 0.010 |
Why?
|
| Laminin | 1 | 1998 | 408 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13382 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1242 | 0.010 |
Why?
|
| Guanidines | 1 | 1997 | 194 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1995 | 49 | 0.010 |
Why?
|
| Myristic Acids | 1 | 1995 | 49 | 0.010 |
Why?
|
| Ionomycin | 1 | 1995 | 110 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 4804 | 0.010 |
Why?
|
| Membranes | 1 | 1995 | 165 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 618 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 925 | 0.010 |
Why?
|
| Bradykinin | 1 | 1995 | 208 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2261 | 0.010 |
Why?
|
| Epididymis | 1 | 1997 | 227 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1995 | 249 | 0.010 |
Why?
|
| Endothelium | 1 | 1997 | 764 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1999 | 973 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 2202 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1999 | 1415 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 871 | 0.010 |
Why?
|
| Arginine | 1 | 1997 | 933 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1810 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1998 | 1185 | 0.010 |
Why?
|
| Cytosol | 1 | 1995 | 886 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 1703 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 2561 | 0.010 |
Why?
|
| Adipocytes | 1 | 1998 | 1187 | 0.010 |
Why?
|
| Point Mutation | 1 | 1996 | 1595 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 2048 | 0.010 |
Why?
|
| Cysteine | 1 | 1995 | 891 | 0.010 |
Why?
|
| Leptin | 1 | 1998 | 1595 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 3074 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1998 | 1896 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 39913 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1997 | 2208 | 0.010 |
Why?
|
| United States | 1 | 2017 | 72272 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 5780 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1998 | 2878 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1998 | 3998 | 0.000 |
Why?
|
| Pregnancy | 1 | 2009 | 29868 | 0.000 |
Why?
|
| Sulfonamides | 1 | 1997 | 1977 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1997 | 3309 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 9586 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1997 | 7402 | 0.000 |
Why?
|
| Middle Aged | 2 | 2004 | 220584 | 0.000 |
Why?
|
| Adult | 2 | 2004 | 220969 | 0.000 |
Why?
|
| Child | 1 | 2004 | 80079 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 88234 | 0.000 |
Why?
|
| Aged | 1 | 1997 | 169042 | 0.000 |
Why?
|